Loss of Physiological Reserve as a Mechanism of Multimorbidity

Abstract

Loss of physiological reserve is increasingly recognized as a central mechanism underlying multimorbidity, particularly in aging populations. This article critically reviews the current evidence on how diminished reserve across multiple organ systems contributes to the pathogenesis, clinical manifestation, and complexity of multimorbidity. The review integrates recent epidemiological data, mechanistic insights, risk factors, clinical features, diagnostic approaches, management strategies, emerging therapies, and current international guidelines. The importance of understanding physiological reserve as a dynamic marker for vulnerability, intervention opportunities, and outcome prediction is highlighted for clinicians and healthcare professionals managing multimorbid patients.

Introduction

Multimorbidity, defined as the co-occurrence of two or more chronic conditions in an individual, presents significant challenges to healthcare systems worldwide. Historically, research focused on disease-specific pathways, but recent advances have shifted attention to shared mechanisms such as the loss of physiological reserve. Physiological reserve refers to the body's capacity to withstand stressors and maintain homeostasis. Its depletion is a hallmark of aging and chronic disease, leading to increased vulnerability and adverse health outcomes. Understanding this mechanism is crucial for holistic patient care, risk stratification, and the development of targeted interventions for complex multimorbid patients.

Epidemiology / Disease Burden

Multimorbidity affects over one-third of adults in high-income countries, with prevalence rising sharply with age. Epidemiological studies, such as the UK Biobank and the U.S. National Health and Nutrition Examination Survey (NHANES), reveal that around 65% of those aged 65 and above live with two or more chronic conditions. The burden is amplified by social determinants, with higher rates in populations experiencing socioeconomic deprivation, limited access to care, and lower educational attainment. Loss of physiological reserve is both a consequence and driver of multimorbidity, accelerating decline in functional capacity, increasing hospitalization risk, and compounding healthcare costs.

Pathophysiology

The pathophysiology of loss of physiological reserve in multimorbidity is complex and multifactorial. Key mechanisms include cellular senescence, chronic low-grade inflammation ("inflammaging"), mitochondrial dysfunction, dysregulation of neuroendocrine pathways, and impaired repair processes. These factors lead to diminished adaptive responses in organ systems such as the cardiovascular, renal, respiratory, musculoskeletal, and immune systems. Loss of reserve manifests as reduced ability to compensate for acute stressors (e.g., infection, surgery) and increased susceptibility to decompensation. Recent studies underscore the role of frailty, sarcopenia, and cognitive decline as clinical correlates of declining physiological reserve.

Risk Factors

Risk factors for loss of physiological reserve and subsequent multimorbidity include advanced age, polypharmacy, sedentary lifestyle, poor nutrition, chronic inflammation, and the presence of specific chronic diseases such as diabetes, heart failure, and chronic kidney disease. Genetic predisposition, cumulative exposure to environmental stressors, and psychosocial determinants (e.g., social isolation, depression) further modulate risk. The interplay between modifiable and non-modifiable factors creates a dynamic risk profile, with longitudinal cohort studies indicating that early intervention on lifestyle and comorbidity management may preserve physiological reserve and delay the onset of multimorbidity.

Clinical Features

Clinically, loss of physiological reserve is often insidious, presenting as increased fatigue, reduced exercise tolerance, delayed recovery from illness, and functional decline. Patients may exhibit frailty, sarcopenia, cognitive impairment, and a heightened risk of falls and disability. Multimorbid individuals with low reserve frequently experience atypical disease presentations, drug sensitivity, and diminished response to standard therapies. Comprehensive geriatric assessment (CGA) tools, such as the Clinical Frailty Scale and gait speed measurement, are valuable for assessing reserve and predicting outcomes.

Diagnosis

The diagnosis of loss of physiological reserve in the context of multimorbidity relies on a combination of clinical assessment, functional testing, and the use of validated instruments. Biomarkers such as C-reactive protein, interleukin-6, and markers of sarcopenia (e.g., creatinine/cystatin C ratio) provide objective measures of systemic reserve. Imaging modalities (e.g., DXA for muscle mass, echocardiography for cardiac reserve) and functional tests (e.g., 6-minute walk test, grip strength) are integral to a comprehensive evaluation. Multidimensional assessment is essential for risk stratification and individualized care planning.

Treatment & Management

Management strategies for patients with loss of physiological reserve and multimorbidity emphasize individualized, multidisciplinary approaches. Key interventions include optimizing medical therapy, minimizing polypharmacy, promoting physical activity and rehabilitation, addressing nutritional deficiencies, and providing psychosocial support. Care coordination across specialties and integration of palliative care principles are recommended to address symptom burden and enhance quality of life. Regular monitoring of functional status and proactive management of acute exacerbations are essential to prevent rapid decline.

Recent Advances / Emerging Therapies

Recent advances in the field include the application of geroscience-based interventions, such as senolytics, anti-inflammatory agents, and mitochondrial-targeted therapies aimed at preserving or restoring physiological reserve. Digital health technologies, including wearable sensors and remote monitoring, enable real-time assessment of reserve and early detection of decompensation. Novel care models, such as the Integrated Care for Older People (ICOPE) framework by the WHO, advocate for comprehensive, patient-centered management of multimorbidity with a focus on maintaining reserve and functional independence.

Guideline Recommendations

International guidelines, including those from the National Institute for Health and Care Excellence (NICE) and the European Geriatric Medicine Society (EuGMS), emphasize the importance of assessing physiological reserve and frailty in multimorbid patients. Recommendations include routine use of validated assessment tools, individualized care planning, deprescribing where appropriate, and prioritizing interventions that preserve function and quality of life. The guidelines advocate for interdisciplinary collaboration and shared decision-making, recognizing the heterogeneity of multimorbidity and the need for tailored management strategies.

Conclusion

Loss of physiological reserve is a pivotal mechanism driving the development and progression of multimorbidity, with profound implications for clinical care. Recognizing and addressing diminished reserve enables healthcare professionals to better predict risk, tailor interventions, and improve outcomes for complex, multimorbid patients. Ongoing research into the biological underpinnings and innovative therapies holds promise for mitigating functional decline and enhancing resilience in vulnerable populations. Integration of reserve assessment into routine practice is essential for advancing patient-centered care in an era of rising multimorbidity.